600056 中國醫藥
按盤價 
8.940 +0.030 (+0.337%) | 2026/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 16,951,925 | -0.73% | 35,361,622 | 35,243,414 | 38,824,431 | 37,592,650 | |
| 減：營業總成本 | 16,372,550 | -0.40% | 34,112,388 | 34,019,356 | 37,501,895 | 36,137,940 | |
| 其中:營業成本 | 15,110,394 | -1.20% | 31,647,847 | 31,459,671 | 34,440,814 | 32,845,786 | |
| 財務費用 | 125,278 | -1,381.55% | 110,016 | 211,480 | 112,038 | 138,317 | |
| 資產減值損失 | (3,913) | -1,572.50% | (150,704) | (180,391) | (13,539) | (280,660) | |
| 公允價值變動收益 | -- | -- | (2,211) | 127,467 | 985 | 1,922 | |
| 投資收益 | 12,527 | 32.46% | (68,010) | (64,072) | (15,792) | 51,001 | |
| 其中：對聯營企業和合營企業的投資收益 | 34,922 | 21.49% | 31,367 | 18,736 | 77,043 | 93,219 | |
| 營業利潤 | 477,896 | -8.95% | 1,022,988 | 986,593 | 1,672,334 | 1,199,698 | |
| 利潤總額 | 480,338 | -7.76% | 999,295 | 1,008,156 | 1,640,556 | 1,196,127 | |
| 減：所得稅費用 | 168,118 | 15.63% | 324,659 | 274,343 | 398,435 | 307,699 | |
| 淨利潤 | 312,220 | -16.81% | 674,636 | 733,814 | 1,242,120 | 888,428 | |
| 減：非控股權益 | 63,109 | -22.44% | 201,407 | 151,232 | 194,081 | 152,827 | |
| 股東淨利潤 | 249,111 | -15.26% | 473,229 | 582,582 | 1,048,039 | 735,601 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.167 | -15.27% | 0.316 | 0.390 | 0.701 | 0.492 | |
| 每股派息 (元) * | -- | -- | 0.095 | 0.107 | 0.210 | 0.148 | |
| 每股淨資產 (元) * | 8.004 | 2.13% | 7.912 | 7.902 | 7.728 | 7.230 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 18/09/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
